Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ferring Pharmaceuticals
With
Memorial Sloan Kettering Cancer Center
Duke Clinical Research Institute
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Advanced prostate cancer
Indication to initiate androgen deprivation therapy (ADT)
Predefined cardiovascular disease
You may not be if
Previous or current hormonal management of prostate cancer (unless terminated at least 12 months prior to trial)
Acute cardiovascular disease in the previous 30 days
Clareo Health | A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
